On Tuesday, the CDC’s National Center for Health Statistics released its latest report analyzing data on the state of obesity ...

The Senate HELP Committee held a hearing to address the high cost of semaglutide drugs, finding that many patients cannot ...

If a woman is already in a "prediabetic" state in her teen or college years, her odds for a serious complication of pregnancy ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...

Senate HELP Chairman Bernie Sanders launches another salvo in drug pricing war, this one aimed at popular weight loss drugs.

Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on ...

Washington — Lawmakers will question the maker of popular weight loss drugs Ozempic and Wegovy during a Senate committee hearing on Tuesday focused on what Sen. Bernie Sanders has called “ ...

Novo Nordisk’s weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

CEO Lars Fruergaard Jørgensen agreed today, during a Senate committee hearing, to sit down with lawmakers and pharmacy ...

She's once again calling for HHS to exercise "march-in" rights, which let the government create alternatives to patented ...

Leading pharmacy benefit managers are reportedly willing to expand coverage for Novo Nordisk’s (NVO) popular diabetes and ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...